VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that Jeff Baxter, President and CEO, will present at the H.C. Wainwright 21st Annual Global Investment Conference in New York City on Tuesday, September 10, 2019, at 8:20 AM ET.

  • Event: H.C. Wainwright 21st Annual Global Investment Conference
  • Date: Tuesday, September 10, 2019
  • Time: 8:20 – 8:45 AM ET
  • Webcast: http://wsw.com/webcast/hcw5/vbiv/

A live webcast of the presentation may also be accessed by visiting the Investors page of VBI’s website at www.vbivaccines.com.